Show simple item record

dc.contributor.authorColeman, C.M.
dc.contributor.authorFrieman, M.B.
dc.date.accessioned2020-03-27T15:13:16Z
dc.date.available2020-03-27T15:13:16Z
dc.date.issued2015
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84949220116&doi=10.1002%2f9780471729259.mc15e02s37&partnerID=40&md5=6f2999f2d1fafd854c3a3f11c62a3253
dc.identifier.urihttp://hdl.handle.net/10713/12410
dc.description.abstractMiddle East respiratory syndrome coronavirus (MERS-CoV) is an emerging highly pathogenic respiratory virus. Although MERS-CoV only emerged in 2012, we and others have developed assays to grow and quantify infectious MERS-CoV and RNA products of replication in vitro. MERS-CoV is able to infect a range of cell types, but replicates to high titers in Vero E6 cells. Protocols for the propagation and quantification of MERS-CoV are presented.en_US
dc.description.urihttps://doi.org/10.1002/9780471729259.mc15e02s37en_US
dc.language.isoen_USen_US
dc.publisherBlackwell Publishing Inc.en_US
dc.relation.ispartofCurrent Protocols in Microbiology
dc.subjectCoronavirusen_US
dc.subjectInfectionen_US
dc.subjectMERSen_US
dc.subjectPlaque assayen_US
dc.subjectQuantificationen_US
dc.subjectVirologyen_US
dc.titleGrowth and quantification of MERS-CoV infectionen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/9780471729259.mc15e02s37
dc.identifier.pmid26344219
dc.identifier.ispublishedNo


This item appears in the following Collection(s)

Show simple item record